Dr. Deepa Kamakshi Chellappa, MD

Dr. Chellappa practices at Lankenau Medical Center in Wayne, Pennsylvania.

Dr. Chellappa's NPI, 1457811051, was assigned on March 21, 2019. Dr. Chellappa holds Pennsylvania license MD478228.

Dr. Chellappa's primary practice is Lankenau Medical Center, at 100 E Lancaster Ave, Wayne, PA 19087 in Delaware County. The practice phone is (610) 645-2000.

Dr. Chellappa's primary practice is Lankenau Medical Center in Wayne, Pennsylvania. Dr. Chellappa is also affiliated with Lankenau Medical Center. The medical group on file is Penn Medicine Lancaster General Health. Dmand AI also links Dr. Chellappa to 1 more hospital, 1 home health agency and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Chellappa practices, 3 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Chellappa's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Chellappa is licensed in Pennsylvania.

CMS data shows 303 Medicare services from Dr. Chellappa across 5 procedure codes in 2024, for 173 Medicare patients. Medicare paid $20,961 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 173 Medicare patients who saw Dr. Chellappa in 2024. The largest group is 65 to 74, with 65 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 43% are also on Medicaid. Their average risk score is 2.26, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Chellappa's median patient age at 55, with 65% women.

In 2024, Dr. Chellappa wrote 1,047 Medicare Part D claims for 193 patients. 82% of them were for generic drugs. CMS names the drug for 705 of them, across 31 drugs with 11 or more claims each, at $86,188 in total drug cost. In 2023, CMS named 11 claims across 1 drug.

Dr. Chellappa accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Chellappa as offering telehealth.

Dmand AI links 4 papers to Dr. Chellappa, published from 2013 to 2016. The most frequent topics are Mice, Inbred C57BL. Dr. Chellappa's most frequent co-authors are Kevin G. Munjal, MD and Aidan Levine Neustadtl.

CMS Open Payments shows 1 general payment to Dr. Chellappa from 1 drug or device company in 2024. Food and beverage make up the largest share, 100% of the total. Dexcom, Inc. paid the most, $23.